TAK Stock Predictions
| Recent TAK Stock Price | TAK Stock Predictions | |
| $13.37 |  +28.42% |
$17.17 |
| Recent TAK Analyst Ratings Breakdown, Making TAK Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 3 | 3 | 3 | 3 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 1 | 1 | 1 | 1 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.5 | 1.5 | 1.5 | 1.5 |
For the TAK stock predictions from the analysts covering Takeda Pharmaceutical Co Ltd, we have collected all of the individual TAK stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering TAK (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TAK stock predictions may vary widely, another useful metric to consider is the median TAK stock prediction, which represents the price at which half of the analysts
made TAK stock predictions that were higher and half made TAK stock predictions that were lower. This makes for a different take on the TAK stock predictions out there, as compared to average or mean.
And that median across all the individual TAK stock predictions was: $17.2 as of 2024-04-15.
The very highest of the TAK stock predictions for one year price target was $20.0, while the very lowest of the TAK stock predictions in the analyst group was
$14.3 (with a standard deviation of $2.85). Get the latest Zacks research report on TAK — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• LEVL Stock Predictions
• DX Stock Predictions
• ESSA Stock Predictions
• UAL Stock Predictions
• TDOC Stock Predictions
• ATSG Stock Predictions
• ADMA Stock Predictions
• IMMU Stock Predictions
• SLP Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free TAK Email Alerts:
Avg. Broker Rec.
 
|
Strong Buy (3.50 out of 4) 60th percentile
(ranked higher than approx. 60% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
